Company: IOBT
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047744
Chunk: 314

Company: IO Biotech, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1B
Chunk 314
---
 our Amendment No. 1 to Registration Statement on Form S-1/A dated October 26, 2021 and incorporated herein by reference) 

    10.15†
     
    Addendum to Service Agreement, dated April 1, 2021, by and between IO Biotech ApS and Mai-Britt Zocca (filed as an exhibit to our Amendment No. 1 to Registration Statement on Form S-1/A dated October 26, 2021 and incorporated herein by reference)

    10.16#
     
    Clinical Trial Collaboration and Supply Agreement by and among IO Biotech ApS, MSD International GmbH, and MSD International Business GmbH, dated as of November 30, 2021 (filed as an exhibit to our Current Report on Form 8-K dated November 30, 2021 and incorporated herein by reference)

    10.17
     
    Common Stock Sales Agreement, dated as of February 15, 2023, by and between IO Biotech, Inc. and Cowen and Company LLC (filed as an exhibit to our Form 8-K dated February 15, 2023 and incorporated herein by reference). 

    10.18
     
    Finance Contract, dated December 19, 2024, by and between IO Biotech ApS and the European Investment Bank (filed as an exhibit to our Form 8-K dated December 20, 2024 and incorporated herein by reference)

    10.19
     
    Guarantee Agreement, dated December 19, 2024, by and between IO Biotech, Inc. and the European Investment Bank (filed as an exhibit to our Form 8-K dated December 20, 2024 and incorporated herein by reference)

    10.20
     
    Side Letter, dated December 19, 2024, by and between IO Biotech ApS and the European Investment Bank (filed as an exhibit to our Form 8-K dated December 20, 2024 and incorporated herein by reference)

    10.21
     
    Warrant Issuance Agreement, dated December 19, 2024, by and between IO Biotech, Inc. and the European Investment Bank (filed as an exhibit to our Form 8-K dated December 20, 2024 and incorporated herein by reference)

    10.22
     
    Registration Rights Agreement, dated December 19, 2024,